Image default
Water News

Zydus Cadila gets USFDA nod for generic drug


New Delhi: Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to marketAlbuteroltablets, used to treat shortness of breath caused by breathing problems such asasthma. The company has received final approval from the US Food and Drug Administration (USFDA) to market its product, which is a generic version of Proventil tablets, Zydus Cadila said in a statement.

Albuterol is a bronchodilator which helps open up the airways in the lungs to make it easier to breathe. The medicine is used to treat and to prevent bronchospasm.

The drug firm said the product would be manufactured at the group’s formulation manufacturing facility at SEZ, Ahmedabad.

Zydus Cadila now has 310 approvals and so far filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process in 2003-04.

(Catch all theBusiness News,Breaking NewsEvents andLatest NewsUpdates onThe Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Source

Related posts

Delta Plus labeled ‘variant of concern’: What you should know about the variant

TheEarthLab

Ultrafast lasers probe elusive chemistry at the liquid-liquid interface

TheEarthLab

‘No need to panic’: Indian vaccines will work against ‘Delta Plus’ COVID variant, says health expert

TheEarthLab

Leave a Comment